Search This Blog

Tuesday, March 31, 2026

ImmunityBio $100 m financing, including $75 m non-dilutive

ImmunityBio announces $100 million financing, including $75 million non-dilutive funding

  • Financing will support global expansion and advancement of ImmunityBio's immunotherapy pipeline.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.